These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2296618)

  • 1. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.
    Samanin R; Mennini T; Bendotti C; Barone D; Caccia S; Garattini S
    Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.
    Neill JC; Cooper SJ
    Psychopharmacology (Berl); 1989; 97(2):213-8. PubMed ID: 2498930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine.
    Rowland N; Carlton J
    Psychopharmacology (Berl); 1983; 81(2):155-7. PubMed ID: 6415747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1992; 106(2):228-34. PubMed ID: 1532259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms.
    Garattini S; Samanin R
    Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ; Burton MJ
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences among 'serotonergic' anorectics in a cross-tolerance paradigm: do they all act on serotonin systems?
    Rowland N; Antelman SM; Kocan D
    Eur J Pharmacol; 1982 Jun; 81(1):57-66. PubMed ID: 7117371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
    Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine.
    Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY
    J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.